2426 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2025
JOURNALInternational journal of pharmaceutics
PREMIER AUTEURAbad EH
TITREEnsuring colloidal stability of cisplatin-loaded mesoporous silica nanoparticles: from synthesis to cytotoxicity assays.
ANNÉE2025
JOURNALBMC neurology
PREMIER AUTEURCezar M
TITREManaging paraneoplastic GABAR-related limbic encephalitis in a patient with a small cell lung cancer receiving an Immune-Checkpoint Inhibitor (ICI) therapy: description of a case report.
ANNÉE2025
JOURNALPituitary
PREMIER AUTEURDelemer B
TITRELoss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5).
ANNÉE2025
JOURNALCancer imaging : the official publication of the International Cancer Imaging Society
PREMIER AUTEURLaich M
TITREAssociation between induced organ atrophy assessed by artificial intelligence-generated automatic segmentation and efficacy of bevacizumab in combination with chemotherapy in metastatic colorectal cancer.
ANNÉE2025
JOURNALWorld journal of surgical oncology
PREMIER AUTEURBerna J
TITREPredictive factors for breast conserving surgery after neoadjuvant chemotherapy in breast cancer.
ANNÉE2025
JOURNALBrazilian journal of anesthesiology (Elsevier)
PREMIER AUTEURRaft J
TITREAnalgesia nociception index as a tool to assess the effectiveness of paravertebral block in total mastectomy: a prospective cohort study.
ANNÉE2025
JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
PREMIER AUTEUREber J
TITREDelineation of organs at risk in radiotherapy and perspectives.
ANNÉE2025
JOURNALCurrent oncology (Toronto, Ont.)
PREMIER AUTEURBischoff H
TITREEvolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review.
ANNÉE2025
JOURNALCancer research
PREMIER AUTEURFumet JD
TITRETumor-Associated Macrophages Produce PGE2 to Promote CD8+ T Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite Stable Colorectal Cancer.
ANNÉE2025
JOURNALThe Lancet. Oncology
PREMIER AUTEURKim S
TITREEzabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques